CLINICAL_TRIALS
trial_result
· 2020-03-03
Clinical Trial Update: Evolocumab for PCSK9 Lowering in Early Acute Sepsis (The PLEASe Study) [Phase 2]
Summary
A Phase 2 clinical trial update investigating evolocumab for PCSK9 lowering in early acute sepsis (PLEASe Study).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of British Columbia | Conditions: Sepsis | Phase 2 | Status: UNKNOWN